Anon (1983) British Herbal Pharmacopeia. Keighley: British Herbal Medicine Association
Backhauss C Krieglstein J (1992) Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents. Eur J Pharmacol 215(2-3):265-9
BAH (2001) 'Summary translation of section describing the cases in “Draft statement of two German pharmaceutical associations, Bundersverband der Arzneimittel Herstell e. V. (BAH) and Bunderverband der Pharmazeutischen Indusctrie e. V. ( BPI)” summary translation' di Angela Grunwald per il TMEC
Barguil Y. (2001) “Kava and gamma-glutamyltransferase increase: hepatic enzymatic induction or liver function alteration.” Electronic letter published http:/bmj.com 21 March 2001 in response to Escher M, Desmeules J, Giostra E et al. Drug points: Hepatitis associated with kava, a herbal remedy for anxiety. BMJ; 322: 139.
Boonen G, Haberlein H (1998) Influence of genuine kavapyrone enantiomers on the GABA-A binding site.Planta Med ;64(6):504-6
Chanwai, L., (2000) 'Kava toxicity.' Emergency Medicine 12, 142-145
Cheng D Lidgard RO Duffield PH Duffield AM Brophy JJ (1988) Identification by methane chemical ionization gas chromatography/mass spectrometry of the products obtained by steam distillation and aqueous acid extraction of commercial Piper methysticum. Biomed Environ Mass Spectrom 17(5):371-6
Clough, A., et al. (2000) 'Kava in Arnhem Land: a review of consumption and its social correlates'. Drugs and Alcohol Review 19(3), 319-323
d'Abbs P, Burns C. (1997) “Draft report on inquiry into the issue of kava regulation.” [Prepared for the Sessional Committee on the Use and Abuse of Alcohol by the Community.] Menzies School of Health Research, Darwin.
Davies LP Drew CA Duffield P Johnston GA Jamieson DD (1992) Kava pyrones and resin: studies on GABAA, GABAB and benzodiazepine binding sites in rodent brain. Pharmacol Toxicol 71(2):120-6
De Leo, V., et al., (2001) 'Evaluation of combining kava extract with hormone replacement therapy in the treatment of postmenopausal anxiety'. Maturitas 39, 185-188
Duffield AM Jamieson DD Lidgard RO Duffield PH Bourne DJ (1989) Identification of some human urinary metabolites of the intoxicating beverage kava. J Chromatogr 475:273-81
Duffield PH Jamieson DD Duffield AM (1989) Effect of aqueous and lipid-soluble extracts of kava on the conditioned avoidance response in rats. Arch Int Pharmacodyn Ther 301:81-90
Ellingwood, F. (1919) American Materia Medica, Therapeutics and Pharmacognosy. Reprinted by Oregon: Ec;lectic Medical Publications
Felter, H., Lloyd, J. (1903) reprinted 1983. King's American dispensatory. Portland: Eclectic Medical Publications
German Commission E (1990) “Piperis methystici rhizoma (Kava-Kava-Wurzelstock). German Commission E Monograph” Bundesanzeiger , 101 (1)
Gleitz J Beile A Peters T (1995) (+/-)-Kavain inhibits veratridine-activated voltage-dependent Na(+)- channels in synaptosomes prepared from rat cerebral cortex. Neuropharmacology 34(9):1133-8
Gleitz J Friese J Beile A Ameri A Peters T (1996) Anticonvulsive action of (+/-)-kavain estimated from its properties on stimulated synaptosomes and Na+ channel receptor sites. Eur J Pharmacol 315(1):89-97
Gleitz J, Beile A, Wilkens P, Ameri A, Peters T (1997) Antithrombotic action of the kava pyrone (+)-kavain prepared from Piper methysticum on human platelets. Planta Med;63(1):27-30
Greenwood-Robinson, M. (1999) Kava. Dell Publishing
Grunze H, et al. (2001) 'Kava pyrones exert effects on neuronal transmission and transmembraneous cation currents similar to established mood stabilizers--a review'. Prog Neuropsychopharmacol Biol Psychiatry 25(8), 1555-70
Haberlein, H., et al., (1997) 'Piper methysticum: enantiomeric separation of kavapyrones by HPLC'. Planta Medica 63, 63-65
Hänsel R, Keller K, Rimpler H and Schneider G (eds.) (1994) Hagers Handbuch der Pharmazeutischen Praxis, 5th ed. Volume 6: Drogen P-Z. Berlin-Heidelberg-New York-London: Springer-Verlag:191-221
He, X, et al., (1997) 'Electrospray HPLC-MS in phytochemical analysis of Kava (Piper methysticum) extract.' Planta Medica 63, 70-74
Hope BE Massey DG Fournier-Massey G (1993) Hawaiian materia medica for asthma. Hawaii Med J 52(6):160-6
Jamieson DD Duffield PH Cheng D Duffield AM (1989) Comparison of the central nervous system activity of the aqueous and lipid extract of kava (Piper methysticum). Arch Int Pharmacodyn Ther 301:66-80
Jamieson DD, Duffield PH. (1990) “Positive interaction of ethanol and kava resin in mice. Clin Exp Pharmacol Physiol.; 17(7): 509-14
Johnson, T. (1999) CRC ethnobotany desk reference. Florida: CRC Press
Jussofie A Schmiz A Hiemke C (1994) Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain. Psychopharmacology (Berl) 116(4):469-74
Kinzler E, Kromer J, Lehmann E. (1991) Effect of a special kava extract in patients with anxiety-, tension, and excitation states of non-psychotic genesis. Double blind study with placebos over four weeks [in German]. Arzneimforsch.;41:584-588.
Langosch JM, Normann C, Schirrmacher K, Berger M, Walden J (1998) The influence of (+/-)-kavain on population spikes and long-term potentiation in guinea pig hippocampal slices; Comp Biochem Physiol A Mol Integr 120(3):545-9
Lebot V and Levesque J. (1996) “Genetic control of kavalactone chemotypes in Piper methysticum cultivars.” Phytochemistry, 43, 397-403.
Lebot, V., et al., (1997) Kava - the Pacific Elixir. Vermont: Healing Arts Press
Lehmann E, et al. (1996) Efficacy of special kava extract (Piper methysticum) in patients with states of anxiety, tension and excitedness of non-mental origin-A double blind placebo controlled study of four weeks treatment. Phytomedicine.;3:113-119.
Lindenberg Von D, Pitule-Schodel H. D (1990) L-Kavain in comparison with oxazepam in anxiety states. Double-blind clinical trial. Forschr Med.;108:50-54.
Locher CP Burch MT Mower HF Berestecky J Davis H Van Poel B Lasure A (1995) Vanden Berghe DA Vlietinck AJ Anti-microbial activity and anti-complement activity of extracts obtained from selected Hawaiian medicinal plants. J Ethnopharmacol 49(1):23-32
Mathews JD, Riley MD, Fejo L et al. (1988) “Effects of the heavy usage of kava on physical health: summary of a pilot survey in an Aboriginal community.” Med J Aust; 148: 548-555
Mills, S., Bone, K., (2000) Principles and Practice of Phytotherapy Edinburgh: Churchill Livingstone
Ministero della Salute, Ufficio XII, Direzione generale della sanità pubblica, veterinaria, alimenti e nutrizione. (2002) Circolare 22/1/2002 - 600.12/Ag 45.1/221
Munte TF Heinze HJ Matzke M Steitz J (1993) Effects of oxazepam and an extract of kava roots (Piper methysticum) on event-related potentials in a word recognition task. Neuropsychobiology 27(1):46-53
Norton SA, Ruze P. (1994) “Kava dermopathy.” J. Amer. Acad. Dermatol., 31, 89-97
Nowakowska E, Ostrowicz A, Chodera A (1998) [Kava-kava preparations--alternative anxiolytics].Pol Merkuriusz Lek;4(21):179-180a
Pittler, M., Ernst, E., (2000) 'Efficacy of Kava Extract for Treating Anxiety: Systematic Review and Meta-Analysis'. Journal of Clinical Psychopharmacology 20(1), 84-89
Rote Liste Service GmbH (edas.) (2001) “Psychopharmaka (Section 71).” Rote Liste 2001 Arzneimittelverzeichnis für Deutschland (einschließlich EU-Zulassungen und estimmter Medizinprodukte. Editio Cantor Verlag,.
Russmann S, Lauterburg BH, Helbling A. (2001) “Kava hepatotoxicity.” Ann Intern Med; 135(1): 68-69
Schirrmacher K, Busselberg D, Langosch JM, Walden J, Winter U, Bingmann D (1999) Effects of (+/-)-kavain on voltage-activated inward currents of dorsal root ganglion cells from neonatal rats. Eur Neuropsychopharmacol ;9(1-2):171-6
Schmidt P. (2000) “Lebernebenwirkungen durch Kava-Extrakt.” Journal für Orthomolecular Medizin 9(4):379-391
Schmitz D Zhang CL Chatterjee SS Heinemann U (1995) Effects of methysticin on three different models of seizure like events studied in rat hippocampal and entorhinal cortex slices. Naunyn Schmiedebergs Arch Pharmacol 351(4):348-55
Schulz, V., et al. (1997) Rational phytotherapy. Heidelberg: Springer-Verlag
Seitz U, Ameri A, Pelzer H, Gleitz J, Peters T (1997) Planta Med ;63(4):303-6 Relaxation of evoked contractile activity of isolated guinea-pig ileum by (+/-)-kavain.
Singh YN (1992) Kava: an overview. J Ethnopharmacol 37(1):13-45
Spinella, M. (2001) The Psychopharmacology of Herbal Medicine. Massachusetts: MIT Press
Steiner GG. (2000) “The correlation between cancer incidence and kava consumption.” Hawaii Med J ; 59: 420-422
Stoller R. (2000) “Leberschadigungen unter kava-extrakten.” Schweizerische Arztezeitung; 81(24): 1335-1336
Uebelhack R, Franke L, Schewe HJ (1998) Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava).; Pharmacopsychiatry 31(5):187-92
Volz HP, Kieser M. (1997) Kava-kava extract WS 1490 versus placebo in anxiety disorders-a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry.;30:1-5.
Walden J, von Wegerer J, Winter U, Berger M, Grunze H (1997) Effects of kawain and dihydromethysticin on field potential changes in the hippocampus. Prog Neuropsychopharmacol Biol Psychiatry ;21(4):697-706
Warnecke G. (1991) Psychosomatic dysfunction in the female climacteric. Clinical effectiveness and tolerance of kava extract WS 1490 [in German]. Fortschr Med. 109:119-122.
Whitton, P., et al. (2002) In via di pubblicazione. Vedi sito EHPA www.users.globalnet.co.uk/~ehpa/
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Impostazioni CookieACCETTO
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.